Table 3.
Dynamic pupillary light responses in healthy control participants and post-COVID-19 subjects with and without neurological symptoms at 4 weeks
Healthy controls (n = 30) | With neurological symptoms at 4 weeks (n = 16) | Without neurological symptoms at 4 weeks (n = 19) | P values | |||
---|---|---|---|---|---|---|
With neurological symptoms versus control | Without neurological symptoms versus control | With versus without neurological symptoms | ||||
Initial pupil diameter (mm) | 5.66 ± 0.84 | 5.58 ± 0.78 | 5.66 ± 0.97 | 0.955a | 0.999a | 0.961a |
Amplitude of contraction (mm) | 1.83 ± 0.29 | 1.71 ± 0.30 | 1.78 ± 0.37 | 0.414a | 0.812a | 0.803a |
Latency of contraction (ms) | 258.0 (234.8–276.5) | 285.5 (266.8–300.5) | 283.0 (273.0–311.0) | 0.016b | 0.010b | > 0.999b |
Duration of contraction (ms) | 662.3 ± 89.2 | 576.8 ± 81.2 | 645.7 ± 93.4 | 0.008a | 0.800a | 0.064a |
Velocity of contraction (mm/s) | 5.67 ± 0.94 | 5.59 ± 0.92 | 5.38 ± 1.04 | 0.965a | 0.577a | 0.801a |
Latency of dilation (ms) | 911.4 ± 80.0 | 861.5 ± 76.0 | 918.6 ± 105.0 | 0.162a | 0.958a | 0.139a |
Duration of dilation (ms) | 1575.6 ± 86.3 | 1602.4 ± 97.8 | 1553.5 ± 108.8 | 0.641a | 0.715a | 0.298a |
Velocity of dilation (mm/s) | 1.69 (1.52–1.84) | 1.58 (1.46–1.76) | 1.59 (1.27–1.64) | 0.172b* |
Data are expressed as mean ± SD for parametric variables and median (IQR) for non-parametric variables. The bold P values represent statistically significant differences
*Pairwise comparisons were not performed as the overall test did not show a significant difference among groups
aOne-way ANOVA test followed by post-hoc Tukey test, bKruskal–Wallis test followed by post-hoc Dunn’s test with adjusted P values using Benjamini–Hochberg procedure